Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
alglucosidase alfa (myozyme) (1 trial)
val-1221 (1 trial)
Glycogen Storage Disease Type II (Phase 2)
Trials (1 total)
Trial APIs (2 total)